{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:03:32Z","timestamp":1790694212297,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s10549-013-2654-3","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T05:00:39Z","timestamp":1375419639000},"page":"567-575","source":"Crossref","is-referenced-by-count":119,"title":["Therapeutic effect of \u03b2-blockers in triple-negative breast cancer postmenopausal women"],"prefix":"10.1007","volume":"140","author":[{"given":"Edoardo","family":"Botteri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Munzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rotmensz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Santillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Zanelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Adamoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colleoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,3]]},"reference":[{"issue":"12","key":"2654_CR1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.amjcard.2010.08.023","volume":"106","author":"CV Ram","year":"2010","unstructured":"Ram CV (2010) Beta-blockers in hypertension. Am J Cardiol 106(12):1819\u20131825","journal-title":"Am J Cardiol"},{"issue":"1","key":"2654_CR2","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.eururo.2013.03.045","volume":"64","author":"HH Grytli","year":"2013","unstructured":"Grytli HH, Fagerland MW, Foss\u00e5 SD et al (2013) Association between use of \u03b2-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol 64(1):e11\u2013e12","journal-title":"Eur Urol"},{"issue":"3","key":"2654_CR3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pros.22564","volume":"73","author":"HH Grytli","year":"2013","unstructured":"Grytli HH, Fagerland MW, Foss\u00e5 SD et al (2013) Use of \u03b2-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate 73(3):250\u2013260","journal-title":"Prostate"},{"issue":"19","key":"2654_CR4","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt A, Chavez-Macgregor M, Lei X et al (2011) Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 29(19):2645\u20132652","journal-title":"J Clin Oncol"},{"issue":"19","key":"2654_CR5","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron TI, Connolly RM, Sharp L et al (2011) Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol 29(19):2635\u20132644","journal-title":"J Clin Oncol"},{"issue":"7","key":"2654_CR6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","volume":"1","author":"DG Powe","year":"2010","unstructured":"Powe DG, Voss MJ, Z\u00e4nker KS et al (2010) Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1(7):628\u2013638","journal-title":"Oncotarget"},{"issue":"2","key":"2654_CR7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-011-1505-3","volume":"129","author":"PA Ganz","year":"2011","unstructured":"Ganz PA, Habel LA, Weltzien EK et al (2011) Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat 129(2):549\u2013556","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2654_CR8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/annonc\/mds616","volume":"24","author":"HM Wang","year":"2013","unstructured":"Wang HM, Liao ZX, Komaki R et al (2013) Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol 24(5):1312\u20131319","journal-title":"Ann Oncol"},{"issue":"2","key":"2654_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ygyno.2012.07.102","volume":"127","author":"ES Diaz","year":"2012","unstructured":"Diaz ES, Karlan BY, Li AJ (2012) Impact of beta blockers on epithelial ovarian cancer survival. Gynecol Oncol 127(2):375\u2013378","journal-title":"Gynecol Oncol"},{"issue":"8","key":"2654_CR10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archinternmed.2011.131","volume":"171","author":"V Giorgi De","year":"2011","unstructured":"De Giorgi V, Grazzini M, Gandini S et al (2011) Treatment with \u03b2-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med 171(8):779\u2013781","journal-title":"Arch Intern Med"},{"issue":"10","key":"2654_CR11","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","volume":"20","author":"S Lemeshow","year":"2011","unstructured":"Lemeshow S, S\u00f8rensen HT, Phillips G et al (2011) \u03b2-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomarkers Prev 20(10):2273\u20132279","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2654_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1185\/03007995.2013.772505","volume":"29","author":"M Monami","year":"2013","unstructured":"Monami M, Filippi L, Ungar A et al (2013) Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials. Curr Med Res Opin 29(4):369\u2013378","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2654_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/B:CACO.0000036152.58271.5e","volume":"15","author":"L Perron","year":"2004","unstructured":"Perron L, Bairati I, Harel F et al (2004) Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control 15(6):535\u2013541","journal-title":"Cancer Causes Control"},{"issue":"9","key":"2654_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrclinonc.2011.123","volume":"8","author":"DG Powe","year":"2011","unstructured":"Powe DG, Entschladen F (2011) Targeted therapies: using \u03b2-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol 8(9):511\u2013512","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2654_CR15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrc1820","volume":"6","author":"MH Antoni","year":"2006","unstructured":"Antoni MH, Lutgendorf SK, Cole SW et al (2006) The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 6(3):240\u2013248","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2654_CR16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","volume":"18","author":"SW Cole","year":"2012","unstructured":"Cole SW, Sood AK (2012) Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 18(5):1201\u20131206","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2654_CR17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.18632\/oncotarget.182","volume":"1","author":"HM Schuller","year":"2010","unstructured":"Schuller HM (2010) Beta-adrenergic signaling, a novel target for cancer therapy? Oncotarget 1(7):466\u2013469","journal-title":"Oncotarget"},{"issue":"7","key":"2654_CR18","doi-asserted-by":"crossref","first-page":"e1001363","DOI":"10.1371\/journal.pbio.1001363","volume":"10","author":"JP Campbell","year":"2012","unstructured":"Campbell JP, Karolak MR, Ma Y et al (2012) Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol 10(7):e1001363","journal-title":"PLoS Biol"},{"issue":"7","key":"2654_CR19","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","volume":"15","author":"M Benish","year":"2008","unstructured":"Benish M, Bartal I, Goldfarb Y et al (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15(7):2042\u20132052","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2654_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1024491219366","volume":"80","author":"TL Drell 4th","year":"2003","unstructured":"Drell TL 4th, Joseph J, Lang K et al (2003) Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 80(1):63\u201370","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"2654_CR21","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF et al (2010) The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 70(18):7042\u20137052","journal-title":"Cancer Res"},{"key":"2654_CR22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tips.2011.02.008","volume":"32","author":"CJ Daly","year":"2011","unstructured":"Daly CJ, McGrath JC (2011) Previously unsuspected widespread cellular and tissue distribution of \u03b2-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci 32:219\u2013226","journal-title":"Trends Pharmacol Sci"},{"issue":"16","key":"2654_CR23","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1002\/cncr.26727","volume":"118","author":"L Jansen","year":"2012","unstructured":"Jansen L, Below J, Chang-Claude J et al (2012) Beta blocker use and colorectal cancer risk: population-based case\u2013control study. Cancer 118(16):3911\u20133919","journal-title":"Cancer"},{"issue":"18","key":"2654_CR24","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1200\/JCO.2012.43.9190","volume":"31","author":"GV S\u00f8rensen","year":"2013","unstructured":"S\u00f8rensen GV, Ganz PA, Cole SW et al (2013) Use of \u03b2-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. J Clin Oncol 31(18):2265\u20132272","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2654-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2654-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2654-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:47:20Z","timestamp":1559234840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2654-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["2654"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2654-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}